• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    3.040 -0.090 (-2.88%)
    Streaming Delayed Price Updated: 3:53 PM EST, Mar 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,527
    Open 3.140
    Bid (Size) 2.960 (500)
    Ask (Size) 3.440 (300)
    Prev. Close 3.130
    Today's Range 3.000 - 3.178
    52wk Range 2.940 - 55.20
    Shares Outstanding 620,290
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    New Treatment Dramatically Improves Survival for Patients with Deadly Brain Tumors
    Via Investor Brand Network
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer
    Via Investor Brand Network

    Performance

    YTD
    -42.6%
    -42.6%
    1 Month
    -43.8%
    -43.8%
    3 Month
    -53.3%
    -53.3%
    6 Month
    -51.4%
    -51.4%
    1 Year
    -88.5%
    -88.5%

    More News

    Read More
    New Study Unveils Promising Way to Conduct Brain Surgery Against Cancer
    Via Investor Brand Network
    News headline image
    CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
    Via ACCESS Newswire
    American Science Suffers as Brain Drain Intensifies
    Via Investor Brand Network
    News headline image
    CNS Pharmaceuticals Announces CEO Transition
    Via ACCESS Newswire
    Pressure from Brain Tumors Triggers Self-Destruct Mechanism in Neurons, Study Finds
    Via Investor Brand Network
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints New Executive Leadership Team
    Via Investor Brand Network
    News headline image
    CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
    Via ACCESS Newswire
    Groundbreaking Study Uncovers Why Breast Cancer Metastasizes to the Brain
    Via Investor Brand Network
    New AI Model Predicts Dementia Risk, Cancer Survival and Brain Age
    Via Investor Brand Network
    Topics Artificial Intelligence
    New Photodynamic Therapy Offers Hope Against Brain Cancer
    Via Investor Brand Network
    Researchers Develop Smart Nanoparticles to Destroy Proteins That Cause Diseases
    Via Investor Brand Network
    New Compound Could Become a Transformational Brain Cancer Pill
    Via Investor Brand Network
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Issues Shareholder Letter Outlining Strategic Review and Focus on TPI 287
    Via Investor Brand Network
    New Digital Twin Predicts Outcomes of Brain Cancer Treatments
    Via Investor Brand Network
    Topics Artificial Intelligence
    Penn State to Participate in Researching Potential Treatment for Pediatric Brain Cancer
    Via Investor Brand Network
    Preclinical Study Suggests Combo Therapy Could Treat Glioblastoma
    Via Investor Brand Network
    Experts’ Views on Screen Time and Lifestyle on Pediatric Brain Tumors
    Via Investor Brand Network
    New Blood Test Reveals Whether Treatment is Working for Brain Cancer Patients
    Via Investor Brand Network
    MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer
    Via Investor Brand Network
    Researchers Use Supplements to Produce Remarkable Outcomes in Brain Cancer Treatment
    Via Investor Brand Network
    Optimal Treatment Timing Could Boost Cancer Therapy Efficacy
    Via Investor Brand Network
    Nasal Drops Hold Promise in Fighting Deadly Brain Cancer
    Via Investor Brand Network
    MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast
    Via Investor Brand Network

    Frequently Asked Questions

    Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
    CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
    What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
    The current price of CNS Pharmaceuticals, Inc. - Common Stock is 3.040
    When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 03/03/26 03:53 PM ET
    What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 1.89M
    How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
    CNS Pharmaceuticals, Inc. - Common Stock has 2M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.